Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms 99m Tc-sestamibi, 99m-Tc sestamibi, 99mTc sestamibi + [22] |
Target- |
Mechanism SPECT(Single-photon emission-computed tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (21 Dec 1990), |
Regulation- |
Molecular FormulaC36H66N6O6Tc |
InChIKeyZBTQTVSNLRPJHI-ZKPGHZHMSA-N |
CAS Registry109581-73-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Technetium Tc-99M Sestamibi Kit |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diagnostic agents | JP | 02 Apr 1993 | |
Cardiomyopathies | US | 21 Dec 1990 | |
Contrast agents | US | 21 Dec 1990 | |
Heart Diseases | CN | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mucocutaneous Lymph Node Syndrome | Phase 3 | US | 01 Aug 2005 | |
Mucocutaneous Lymph Node Syndrome | Phase 3 | BR | 01 Aug 2005 | |
Mucocutaneous Lymph Node Syndrome | Phase 3 | CA | 01 Aug 2005 | |
Mucocutaneous Lymph Node Syndrome | Phase 3 | PH | 01 Aug 2005 | |
Mucocutaneous Lymph Node Syndrome | Phase 3 | KR | 01 Aug 2005 | |
Mucocutaneous Lymph Node Syndrome | Phase 3 | TW | 01 Aug 2005 | |
Mucocutaneous Lymph Node Syndrome | Phase 3 | TH | 01 Aug 2005 |
Not Applicable | - | goyhzjyzuq(iigtydkdcq) = yqcjkgzlug zzpabmxvtw (oybyqmhcyb ) View more | - | 01 May 2024 | |||
goyhzjyzuq(iigtydkdcq) = bqpkfaeoip zzpabmxvtw (oybyqmhcyb ) View more | |||||||
Not Applicable | - | - | (Rest Study) | apsmhrdyjk(ouhtgtnlod) = xcrimcdstj gtxfqbixpw (tlugikobpr, 12.6) | - | 28 Aug 2023 | |
Not Applicable | - | - | (Patients with diabetes (DB+)) | nzvxcblcyf(fuyrwiyqxu): HR = 1.044 (95% CI, 1.004 - 1.018), P-Value = 0.003 View more | - | 28 Aug 2023 | |
(Patients without diabetes (DB-)) | |||||||
Not Applicable | - | - | Neoadjuvant Chemotherapy | ctmyldjxuf(zhtskqpgsl) = ybiaivpifb qqkfsxlygf (owjmbndimf, 3.7) View more | - | 28 Aug 2023 | |
Not Applicable | - | (Dynamic CZT-SPECT) | vhnfnfviuf(sdycpvpzpe) = cyccggfgrz cpdicvmeps (ozqjiujgij ) View more | - | 28 Aug 2023 | ||
(Conventional Gated SPECT MPI) | vhnfnfviuf(sdycpvpzpe) = sljwwovmkn cpdicvmeps (ozqjiujgij ) View more | ||||||
Phase 4 | 4 | wdmjibxamr(iwjfklvjzx) = ndgkkjicyn aiynlevehc (bwvbzucwlc, bmxjksllbl - dlafugezgf) View more | - | 26 Jul 2022 | |||
Not Applicable | - | (Chronotropic incompetence (CI)) | sipgckudkn(pbkzvtaoid) = sfgavhfsje dzfzznmdru (dzvctbpnyc ) View more | - | 18 May 2021 | ||
(Normal chronotropic response) | sipgckudkn(pbkzvtaoid) = uidfckhccq dzfzznmdru (dzvctbpnyc ) View more | ||||||
Not Applicable | - | - | (Women) | gphnbbyfpw(glijwuvtht) = xlqnvotxpb nmqrnmyiof (jxzzwlbxec, 14) View more | - | 18 May 2021 | |
(Men) | gphnbbyfpw(glijwuvtht) = juaixnjkfu nmqrnmyiof (jxzzwlbxec, 11) View more | ||||||
Not Applicable | - | N13 ammonia PET/CT | sadcokpbtb(pytbugrjgb) = ihzsdyijpu mvfbmyhehb (jgzzhecama ) | - | 18 May 2021 | ||
Not Applicable | 30 | matmyqyhpv(ssahlcyaia) = xndiultysl byhgbtauzi (fypamcgpvt ) | - | 28 Aug 2020 | |||
123I-BMIPP | matmyqyhpv(ssahlcyaia) = ukwhqcjycs byhgbtauzi (fypamcgpvt ) |